Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis - Data from a population-based registry

被引:30
作者
Wolf, Joachim [1 ]
Safer, Anton [2 ]
Woehrle, Johannes C. [3 ]
Palm, Frederick [1 ]
Nix, Wilfred A. [4 ]
Maschke, Matthias [5 ]
Grau, Armin J. [1 ]
机构
[1] Klinikum Stadt Ludwigshafen, Dept Neurol, D-67063 Ludwigshafen, Germany
[2] Heidelberg Univ, Inst Publ Hlth, Fac Med, Heidelberg, Germany
[3] Katholisches Klinikum, Dept Neurol, Bruderhaus, Koblenz, Germany
[4] Univ Med, Dept Neurol, Mainz, Germany
[5] Krankenhaus Barmherzigen Bruder, Dept Neurol, Trier, Germany
关键词
Amyotrophic lateral sclerosis; Phenotype; Survival; Prognosis; Population register; Frontotemporal dementia; CLINICAL-FEATURES; ALSFRS-R; HETEROGENEITY; PROGRESSION; DIAGNOSIS; FOCALITY;
D O I
10.1016/j.jns.2014.07.033
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: The clinical spectrum of amyotrophic lateral sclerosis (ALS) is characterized by a considerable variation. Different phenotypes have been described by previous studies. We assessed clinical variability and prognostic relevance of these phenotypes in a prospective, population-based cohort of ALS patients in Rhineland-Palatinate, Germany. Methods: Incident ALS cases, diagnosed between October 2009 and September 2012, were prospectively enrolled and classified according to established ALS phenotype classification (bulbar, classic, flail arm, flail leg, pyramidal, respiratory). Survival probability was described using Kaplan-Meier method. Moreover, the influence of an additional frontotemporal dementia (FTD) was analysed. Results: Phenotypes of all 200 patients were determined. Bulbar and classic phenotypes accounted for 75% of all cases. Deterioration of functional impairment during disease progression was lowest in flail leg and pyramidal variants, and most pronounced in bulbar and classic phenotypes. A poor survival prognosis was observed for bulbar, classic or respiratory phenotypes. Patients with an additional FTD showed an even worse outcome. Conclusions: Results suggest that ALS is a heterogeneous disease, as ALS phenotypes differ in disease progression and survival time. Patients classified as suffering from bulbar, classic and respiratory ALS, as well as those with an additional FTD, show a marked reduction of survival time. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:164 / 167
页数:4
相关论文
共 19 条
  • [1] Brooks BR, 1996, ARCH NEUROL-CHICAGO, V53, P141
  • [2] Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study
    Chio, Adriano
    Calvo, Andrea
    Moglia, Cristina
    Mazzini, Letizia
    Mora, Gabriele
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (07) : 740 - 746
  • [3] Prognostic factors in ALS: A critical review
    Chio, Adriano
    Logroscino, Giancarlo
    Hardiman, Orla
    Swingler, Robert
    Mitchell, Douglas
    Beghi, Ettore
    Traynor, Bryan G.
    [J]. AMYOTROPHIC LATERAL SCLEROSIS, 2009, 10 (5-6): : 310 - 323
  • [4] Quantitating progression in ALS
    de Carvalho, M
    Scotto, M
    Lopes, A
    Swash, M
    [J]. NEUROLOGY, 2005, 64 (10) : 1783 - 1785
  • [5] Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia
    Elamin, M.
    Phukan, J.
    Bede, P.
    Jordan, N.
    Byrne, S.
    Pender, N.
    Hardiman, O.
    [J]. NEUROLOGY, 2011, 76 (14) : 1263 - 1269
  • [6] Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups
    Ganesalingam, Jeban
    Stahl, Daniel
    Wijesekera, Lokesh
    Galtrey, Clare
    Shaw, Christopher E.
    Leigh, P. Nigel
    Al-Chalabi, Ammar
    [J]. PLOS ONE, 2009, 4 (09):
  • [7] Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS
    Gordon, P. H.
    Cheng, B.
    Katz, I. B.
    Mitsumoto, H.
    Rowland, L. P.
    [J]. NEUROLOGY, 2009, 72 (22) : 1948 - 1952
  • [8] Amyotrophic lateral sclerosis
    Kiernan, Matthew C.
    Vucic, Steve
    Cheah, Benjamin C.
    Turner, Martin R.
    Eisen, Andrew
    Hardiman, Orla
    Burrell, James R.
    Zoing, Margaret C.
    [J]. LANCET, 2011, 377 (9769) : 942 - 955
  • [9] Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS
    Kimura, F
    Fujimura, C
    Ishida, S
    Nakajima, H
    Furutama, D
    Uehara, H
    Shinoda, K
    Sugino, M
    Hanafusa, T
    [J]. NEUROLOGY, 2006, 66 (02) : 265 - 267
  • [10] ALSFRS-R score and its ratio: A useful predictor for ALS-progression
    Kollewe, Katja
    Mauss, Ulrike
    Krampfl, Klaus
    Petri, Susanne
    Dengler, Reinhard
    Mohammadi, Bahram
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 275 (1-2) : 69 - 73